FDA Hosts Public Workshop to Discuss Clinical Trials for Diverse Populations

Summary

The FDA, in partnership with the Johns Hopkins Center of Excellence in Regulatory Science and Innovation, is hosting a public meeting to discuss approaches to designing clinical trials and analyzing subgroup data for therapeutic product development and life-cycle management.